1 Study Coverage 1.1 Opioid Induced Constipation (OIC) Drugs Product Introduction 1.2 Market Segments 1.3 Key Opioid Induced Constipation (OIC) Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Type 1.4.2 Lubiprostone 1.4.3 Methyl Naltrexone Bromide 1.4.4 Naldemedine 1.4.5 Alvimopan 1.4.6 Other 1.5 Market by Application 1.5.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size, Estimates and Forecasts 2.1.1 Global Opioid Induced Constipation (OIC) Drugs Revenue 2015-2026 2.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales 2015-2026 2.2 Global Opioid Induced Constipation (OIC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Opioid Induced Constipation (OIC) Drugs Historical Market Size by Region (2015-2020) 2.3.1 Global Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Opioid Induced Constipation (OIC) Drugs Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Region (2021-2026) 2.4.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Region (2021-2026) 3 Global Opioid Induced Constipation (OIC) Drugs Competitor Landscape by Players 3.1 Global Top Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers 3.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers (2015-2020) 3.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Global Opioid Induced Constipation (OIC) Drugs Manufacturers by Revenue 3.2.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Opioid Induced Constipation (OIC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Opioid Induced Constipation (OIC) Drugs Revenue in 2019 3.2.5 Global Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Opioid Induced Constipation (OIC) Drugs Price by Manufacturers 3.4 Global Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Product Types 3.4.1 Opioid Induced Constipation (OIC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Type (2015-2020) 4.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2015-2020) 4.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2015-2020) 4.1.3 Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Opioid Induced Constipation (OIC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Application (2015-2020) 5.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2015-2020) 5.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2015-2020) 5.1.3 Opioid Induced Constipation (OIC) Drugs Price by Application (2015-2020) 5.2 Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Opioid Induced Constipation (OIC) Drugs Price Forecast by Application (2021-2026) 6 Japan by Players, Type and Application 6.1 Japan Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2015-2026 6.1.1 Japan Opioid Induced Constipation (OIC) Drugs Sales YoY Growth 2015-2026 6.1.2 Japan Opioid Induced Constipation (OIC) Drugs Revenue YoY Growth 2015-2026 6.1.3 Japan Opioid Induced Constipation (OIC) Drugs Market Share in Global Market 2015-2026 6.2 Japan Opioid Induced Constipation (OIC) Drugs Market Size by Players (International and Local Players) 6.2.1 Japan Top Opioid Induced Constipation (OIC) Drugs Players by Sales (2015-2020) 6.2.2 Japan Top Opioid Induced Constipation (OIC) Drugs Players by Revenue (2015-2020) 6.3 Japan Opioid Induced Constipation (OIC) Drugs Historic Market Review by Type (2015-2020) 6.3.1 Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020) 6.3.2 Japan Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2015-2020) 6.3.3 Japan Opioid Induced Constipation (OIC) Drugs Price by Type (2015-2020) 6.4 Japan Opioid Induced Constipation (OIC) Drugs Market Estimates and Forecasts by Type (2021-2026) 6.4.1 Japan Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2021-2026) 6.4.2 Japan Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Type (2021-2026) 6.4.3 Japan Opioid Induced Constipation (OIC) Drugs Price Forecast by Type (2021-2026) 6.5 Japan Opioid Induced Constipation (OIC) Drugs Historic Market Review by Application (2015-2020) 6.5.1 Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020) 6.5.2 Japan Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2015-2020) 6.5.3 Japan Opioid Induced Constipation (OIC) Drugs Price by Application (2015-2020) 6.6 Japan Opioid Induced Constipation (OIC) Drugs Market Estimates and Forecasts by Application (2021-2026) 6.6.1 Japan Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2021-2026) 6.6.2 Japan Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Application (2021-2026) 6.6.3 Japan Opioid Induced Constipation (OIC) Drugs Price Forecast by Application (2021-2026) 7 North America 7.1 North America Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2015-2026 7.2 North America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country 7.2.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2015-2020) 7.2.2 North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2015-2026 8.2 Europe Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country 8.2.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country 8.2.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2015-2026 9.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country 9.2.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2015-2020) 9.2.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2015-2026 10.2 Latin America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country 10.2.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country 10.2.2 Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country 11.2.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Ironwood Pharmaceuticals Inc 12.1.1 Ironwood Pharmaceuticals Inc Corporation Information 12.1.2 Ironwood Pharmaceuticals Inc Description and Business Overview 12.1.3 Ironwood Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered 12.1.5 Ironwood Pharmaceuticals Inc Recent Development 12.2 Daiichi Sankyo Co Ltd 12.2.1 Daiichi Sankyo Co Ltd Corporation Information 12.2.2 Daiichi Sankyo Co Ltd Description and Business Overview 12.2.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Products Offered 12.2.5 Daiichi Sankyo Co Ltd Recent Development 12.3 Pfizer 12.3.1 Pfizer Corporation Information 12.3.2 Pfizer Description and Business Overview 12.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Products Offered 12.3.5 Pfizer Recent Development 12.4 Progenics Pharmaceuticals Inc 12.4.1 Progenics Pharmaceuticals Inc Corporation Information 12.4.2 Progenics Pharmaceuticals Inc Description and Business Overview 12.4.3 Progenics Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered 12.4.5 Progenics Pharmaceuticals Inc Recent Development 12.5 Shionogi & Co., Ltd 12.5.1 Shionogi & Co., Ltd Corporation Information 12.5.2 Shionogi & Co., Ltd Description and Business Overview 12.5.3 Shionogi & Co., Ltd Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered 12.5.5 Shionogi & Co., Ltd Recent Development 12.6 Allergan Plc 12.6.1 Allergan Plc Corporation Information 12.6.2 Allergan Plc Description and Business Overview 12.6.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Products Offered 12.6.5 Allergan Plc Recent Development 12.7 Nektar Therapeutics 12.7.1 Nektar Therapeutics Corporation Information 12.7.2 Nektar Therapeutics Description and Business Overview 12.7.3 Nektar Therapeutics Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Products Offered 12.7.5 Nektar Therapeutics Recent Development 12.8 Purdue Pharma 12.8.1 Purdue Pharma Corporation Information 12.8.2 Purdue Pharma Description and Business Overview 12.8.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Products Offered 12.8.5 Purdue Pharma Recent Development 12.9 S.L.A. Pharma AG 12.9.1 S.L.A. Pharma AG Corporation Information 12.9.2 S.L.A. Pharma AG Description and Business Overview 12.9.3 S.L.A. Pharma AG Sales, Revenue and Gross Margin (2015-2020) 12.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Products Offered 12.9.5 S.L.A. Pharma AG Recent Development 12.10 Mundipharma International Limited 12.10.1 Mundipharma International Limited Corporation Information 12.10.2 Mundipharma International Limited Description and Business Overview 12.10.3 Mundipharma International Limited Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Products Offered 12.10.5 Mundipharma International Limited Recent Development 12.11 Ironwood Pharmaceuticals Inc 12.11.1 Ironwood Pharmaceuticals Inc Corporation Information 12.11.2 Ironwood Pharmaceuticals Inc Description and Business Overview 12.11.3 Ironwood Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered 12.11.5 Ironwood Pharmaceuticals Inc Recent Development 12.12 Takeda Pharmaceutical Company Limited 12.12.1 Takeda Pharmaceutical Company Limited Corporation Information 12.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview 12.12.3 Takeda Pharmaceutical Company Limited Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Takeda Pharmaceutical Company Limited Products Offered 12.12.5 Takeda Pharmaceutical Company Limited Recent Development 12.13 Theravance Biopharma Inc 12.13.1 Theravance Biopharma Inc Corporation Information 12.13.2 Theravance Biopharma Inc Description and Business Overview 12.13.3 Theravance Biopharma Inc Sales, Revenue and Gross Margin (2015-2020) 12.13.4 Theravance Biopharma Inc Products Offered 12.13.5 Theravance Biopharma Inc Recent Development 12.14 Bausch Health 12.14.1 Bausch Health Corporation Information 12.14.2 Bausch Health Description and Business Overview 12.14.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020) 12.14.4 Bausch Health Products Offered 12.14.5 Bausch Health Recent Development 12.15 Cosmo Pharmaceuticals SA 12.15.1 Cosmo Pharmaceuticals SA Corporation Information 12.15.2 Cosmo Pharmaceuticals SA Description and Business Overview 12.15.3 Cosmo Pharmaceuticals SA Sales, Revenue and Gross Margin (2015-2020) 12.15.4 Cosmo Pharmaceuticals SA Products Offered 12.15.5 Cosmo Pharmaceuticals SA Recent Development 12.16 Daewoong Pharmaceutical 12.16.1 Daewoong Pharmaceutical Corporation Information 12.16.2 Daewoong Pharmaceutical Description and Business Overview 12.16.3 Daewoong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.16.4 Daewoong Pharmaceutical Products Offered 12.16.5 Daewoong Pharmaceutical Recent Development 12.17 C.B. Fleet Company 12.17.1 C.B. Fleet Company Corporation Information 12.17.2 C.B. Fleet Company Description and Business Overview 12.17.3 C.B. Fleet Company Sales, Revenue and Gross Margin (2015-2020) 12.17.4 C.B. Fleet Company Products Offered 12.17.5 C.B. Fleet Company Recent Development 12.18 Sucampo Pharmaceuticals 12.18.1 Sucampo Pharmaceuticals Corporation Information 12.18.2 Sucampo Pharmaceuticals Description and Business Overview 12.18.3 Sucampo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.18.4 Sucampo Pharmaceuticals Products Offered 12.18.5 Sucampo Pharmaceuticals Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Opioid Induced Constipation (OIC) Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Opioid Induced Constipation (OIC) Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Opioid Induced Constipation (OIC) Drugs Market Segments Table 2. Ranking of Global Top Opioid Induced Constipation (OIC) Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million) Table 4. Major Manufacturers of Lubiprostone Table 5. Major Manufacturers of Methyl Naltrexone Bromide Table 6. Major Manufacturers of Naldemedine Table 7. Major Manufacturers of Alvimopan Table 8. Major Manufacturers of Other Table 9. Global Opioid Induced Constipation (OIC) Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs) Table 10. Global Opioid Induced Constipation (OIC) Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026 Table 11. Global Opioid Induced Constipation (OIC) Drugs Sales by Regions 2015-2020 (K Pcs) Table 12. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Regions (2015-2020) Table 13. Global Opioid Induced Constipation (OIC) Drugs Revenue by Regions 2015-2020 (US$ Million) Table 14. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Region (2021-2026) (K Pcs) Table 15. Global Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers (2015-2020) (K Pcs) Table 16. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Manufacturers (2015-2020) Table 17. Global Opioid Induced Constipation (OIC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 18. Global Opioid Induced Constipation (OIC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2019) Table 19. Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 20. Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2015-2020) Table 21. Key Manufacturers Opioid Induced Constipation (OIC) Drugs Price (2015-2020) (USD/Pcs) Table 22. Opioid Induced Constipation (OIC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type Table 24. Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drugs Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2015-2020) (K Pcs) Table 27. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2015-2020) Table 28. Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2015-2020) (US$ Million) Table 29. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2015-2020) Table 30. Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs) Table 31. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2021-2026) Table 32. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2015-2020) (K Pcs) Table 33. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Application (2015-2020) Table 34. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Application (2021-2026) Table 35. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Application (2021-2026) Table 36. Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2015-2020) (US$ Million) Table 37. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Application (2021-2026) Table 38. Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) of Key Companies (2015-2020) Table 39. Japan Opioid Induced Constipation (OIC) Drugs Sales Share by Company (2015-2020) Table 40. Japan Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Company (2015-2020) Table 41. Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2015-2020) Table 42. Japan Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2015-2020) Table 43. Japan Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Market Share by Type (2015-2020) Table 44. Japan Opioid Induced Constipation (OIC) Drugs Price (K Pcs) by Type (2015-2020) Table 45. Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2021-2026) Table 46. Japan Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2021-2026) Table 47. Japan Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Market Share by Type (2021-2026) Table 48. Japan Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2021-2026) Table 49. Japan Opioid Induced Constipation (OIC) Drugs Price (K Pcs) by Type (2021-2026) Table 50. Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2015-2020) Table 51. Japan Opioid Induced Constipation (OIC) Drugs Sales Share by Application (2015-2020) Table 52. Japan Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Market Share by Application (2015-2020) Table 53. Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2021-2026) Table 54. Japan Opioid Induced Constipation (OIC) Drugs Sales Share by Application (2021-2026) Table 55. Japan Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Market Share by Application (2021-2026) Table 56. Japan Opioid Induced Constipation (OIC) Drugs Revenue Share by Application (2021-2026) Table 57. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2015-2020) (K Pcs) Table 58. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2015-2020) Table 59. North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 60. North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2015-2020) Table 61. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2015-2020) (K Pcs) Table 62. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2015-2020) Table 63. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 64. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2015-2020) Table 65. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2015-2020) (K Pcs) Table 66. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2015-2020) Table 67. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2015-2020) (US$ Million) Table 68. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2015-2020) Table 69. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2015-2020) (K Pcs) Table 70. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2015-2020) Table 71. Latin Americaa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 72. Latin America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2015-2020) Table 73. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2015-2020) (K Pcs) Table 74. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2015-2020) Table 75. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 76. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2015-2020) Table 77. Ironwood Pharmaceuticals Inc Corporation Information Table 78. Ironwood Pharmaceuticals Inc Description and Business Overview Table 79. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 80. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Table 81. Ironwood Pharmaceuticals Inc Recent Development Table 82. Daiichi Sankyo Co Ltd Corporation Information Table 83. Daiichi Sankyo Co Ltd Description and Business Overview Table 84. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 85. Daiichi Sankyo Co Ltd Product Table 86. Daiichi Sankyo Co Ltd Recent Development Table 87. Pfizer Corporation Information Table 88. Pfizer Description and Business Overview Table 89. Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 90. Pfizer Product Table 91. Pfizer Recent Development Table 92. Progenics Pharmaceuticals Inc Corporation Information Table 93. Progenics Pharmaceuticals Inc Description and Business Overview Table 94. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 95. Progenics Pharmaceuticals Inc Product Table 96. Progenics Pharmaceuticals Inc Recent Development Table 97. Shionogi & Co., Ltd Corporation Information Table 98. Shionogi & Co., Ltd Description and Business Overview Table 99. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 100. Shionogi & Co., Ltd Product Table 101. Shionogi & Co., Ltd Recent Development Table 102. Allergan Plc Corporation Information Table 103. Allergan Plc Description and Business Overview Table 104. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 105. Allergan Plc Product Table 106. Allergan Plc Recent Development Table 107. Nektar Therapeutics Corporation Information Table 108. Nektar Therapeutics Description and Business Overview Table 109. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 110. Nektar Therapeutics Product Table 111. Nektar Therapeutics Recent Development Table 112. Purdue Pharma Corporation Information Table 113. Purdue Pharma Description and Business Overview Table 114. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 115. Purdue Pharma Product Table 116. Purdue Pharma Recent Development Table 117. S.L.A. Pharma AG Corporation Information Table 118. S.L.A. Pharma AG Description and Business Overview Table 119. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 120. S.L.A. Pharma AG Product Table 121. S.L.A. Pharma AG Recent Development Table 122. Mundipharma International Limited Corporation Information Table 123. Mundipharma International Limited Description and Business Overview Table 124. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 125. Mundipharma International Limited Product Table 126. Mundipharma International Limited Recent Development Table 127. Ono Pharmaceutical Co., Ltd Corporation Information Table 128. Ono Pharmaceutical Co., Ltd Description and Business Overview Table 129. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 130. Ono Pharmaceutical Co., Ltd Product Table 131. Ono Pharmaceutical Co., Ltd Recent Development Table 132. Takeda Pharmaceutical Company Limited Corporation Information Table 133. Takeda Pharmaceutical Company Limited Description and Business Overview Table 134. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 135. Takeda Pharmaceutical Company Limited Product Table 136. Takeda Pharmaceutical Company Limited Recent Development Table 137. Theravance Biopharma Inc Corporation Information Table 138. Theravance Biopharma Inc Description and Business Overview Table 139. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 140. Theravance Biopharma Inc Product Table 141. Theravance Biopharma Inc Recent Development Table 142. Bausch Health Corporation Information Table 143. Bausch Health Description and Business Overview Table 144. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 145. Bausch Health Product Table 146. Bausch Health Recent Development Table 147. Cosmo Pharmaceuticals SA Corporation Information Table 148. Cosmo Pharmaceuticals SA Description and Business Overview Table 149. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 150. Cosmo Pharmaceuticals SA Product Table 151. Cosmo Pharmaceuticals SA Recent Development Table 152. Daewoong Pharmaceutical Corporation Information Table 153. Daewoong Pharmaceutical Description and Business Overview Table 154. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 155. Daewoong Pharmaceutical Product Table 156. Daewoong Pharmaceutical Recent Development Table 157. C.B. Fleet Company Corporation Information Table 158. C.B. Fleet Company Description and Business Overview Table 159. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 160. C.B. Fleet Company Product Table 161. C.B. Fleet Company Recent Development Table 162. Sucampo Pharmaceuticals Corporation Information Table 163. Sucampo Pharmaceuticals Description and Business Overview Table 164. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 165. Sucampo Pharmaceuticals Product Table 166. Sucampo Pharmaceuticals Recent Development Table 167. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 168. Key Challenges Table 169. Market Risks Table 170. Main Points Interviewed from Key Opioid Induced Constipation (OIC) Drugs Players Table 171. Opioid Induced Constipation (OIC) Drugs Customers List Table 172. Opioid Induced Constipation (OIC) Drugs Distributors List Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Opioid Induced Constipation (OIC) Drugs Product Picture Figure 2. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Lubiprostone Product Picture Figure 4. Methyl Naltrexone Bromide Product Picture Figure 5. Naldemedine Product Picture Figure 6. Alvimopan Product Picture Figure 7. Other Product Picture Figure 8. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2020 & 2026 Figure 9. Hospital Pharmacies Figure 10. Retail Pharmacies Figure 11. Online Pharmacies Figure 12. Opioid Induced Constipation (OIC) Drugs Report Years Considered Figure 13. Global Opioid Induced Constipation (OIC) Drugs Market Size 2015-2026 (US$ Million) Figure 14. Global Opioid Induced Constipation (OIC) Drugs Sales 2015-2026 (K Pcs) Figure 15. Global Opioid Induced Constipation (OIC) Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 16. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2015-2020) Figure 17. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region in 2019 Figure 18. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2015-2020) Figure 19. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region in 2019 Figure 20. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Manufacturer in 2019 Figure 21. The Top 10 and 5 Players Market Share by Opioid Induced Constipation (OIC) Drugs Revenue in 2019 Figure 22. Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020) Figure 24. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2019 Figure 25. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2015-2020) Figure 26. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type in 2019 Figure 27. Global Opioid Induced Constipation (OIC) Drugs Market Share by Price Range (2015-2020) Figure 28. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020) Figure 29. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2019 Figure 30. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2015-2020) Figure 31. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application in 2019 Figure 32. Japan Opioid Induced Constipation (OIC) Drugs Sales Growth Rate 2015-2026 (K Pcs) Figure 33. Japan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate 2015-2026 (US$ Million) Figure 34. Japan Opioid Induced Constipation (OIC) Drugs Market Share in Global Market 2015-2026 Figure 35. Japan 5 and 10 Largest Opioid Induced Constipation (OIC) Drugs Players Market Share by Revenue in Opioid Induced Constipation (OIC) Drugs in 2019 Figure 36. Japan Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2015-2020) Figure 37. Japan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate by Type in 2015 & 2019 Figure 38. Japan Opioid Induced Constipation (OIC) Drugs Revenue Share by Application (2015-2020) Figure 39. Japan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate by Application in 2015 & 2019 Figure 40. North America Opioid Induced Constipation (OIC) Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 41. North America Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 42. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2019 Figure 43. North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country in 2019 Figure 44. U.S. Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 45. U.S. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. Canada Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 47. Canada Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Europe Opioid Induced Constipation (OIC) Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 49. Europe Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 50. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2019 Figure 51. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country in 2019 Figure 52. Germany Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 53. Germany Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. France Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 55. France Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. U.K. Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 57. U.K. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Italy Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 59. Italy Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Russia Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 61. Russia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 63. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 64. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region in 2019 Figure 65. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region in 2019 Figure 66. China Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 67. China Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Japan Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 69. Japan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. South Korea Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 71. South Korea Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. India Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 73. India Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Australia Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 75. Australia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Taiwan Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 77. Taiwan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Indonesia Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 79. Indonesia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Thailand Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 81. Thailand Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Malaysia Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 83. Malaysia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Philippines Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 85. Philippines Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 86. Vietnam Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 87. Vietnam Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 88. Latin America Opioid Induced Constipation (OIC) Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 89. Latin America Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 90. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2019 Figure 91. Latin America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country in 2019 Figure 92. Mexico Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 93. Mexico Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Brazil Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 95. Brazil Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Argentina Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 97. Argentina Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 98. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Growth Rate 2015-2020 (K Pcs) Figure 99. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 100. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2019 Figure 101. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country in 2019 Figure 102. Turkey Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 103. Turkey Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 105. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. U.A.E Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2020) (K Pcs) Figure 107. U.A.E Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. Porter's Five Forces Analysis Figure 109. Opioid Induced Constipation (OIC) Drugs Value Chain Figure 110. Channels of Distribution Figure 111. Distributors Profiles Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

Ironwood Pharmaceuticals Inc Daiichi Sankyo Co Ltd Pfizer Progenics Pharmaceuticals Inc Shionogi & Co., Ltd Allergan Plc Nektar Therapeutics Purdue Pharma S.L.A. Pharma AG Mundipharma International Limited Ono Pharmaceutical Co., Ltd Takeda Pharmaceutical Company Limited Theravance Biopharma Inc Bausch Health Cosmo Pharmaceuticals SA Daewoong Pharmaceutical C.B. Fleet Company Sucampo Pharmaceuticals